Abstract

Lombardy is the Italian region most affected by COVID-19. We tested the presence of plasma anti-SARS-CoV-2 IgG antibodies in 3985 employees across 7 healthcare facilities in areas of Lombardy with different exposure to the SARS-CoV-2 epidemic. Subjects filled a questionnaire to self-report on COVID-19 symptoms, comorbidities, smoking, regular or remote working, and the exposure to COVID-infected individuals. We show that the number of individuals exposed to the virus depended on the geographical location of the facility, ranging between 3 and 43%, consistent with the spatial variation of COVID-19 incidence in Lombardy, and correlated with family interactions. We observed a higher prevalence of females than males positive for IgG, however the level of antibodies was similar, suggesting a comparable magnitude of the anti-spike antibody response. IgG positivity among smokers was lower (7.4% vs 13.5%) although without difference in IgG plasma levels. We observed 11.9% of IgG positive asymptomatic individuals and another 23.1% with one or two symptoms. Interestingly, among the IgG positive population, 81.2% of subjects with anosmia/dysgeusia and fever were SARS-CoV-2 infected, indicating that these symptoms are strongly associated to COVID-19. In conclusion, the frequency of IgG positivity and SARS-CoV-2 infection is dependent on the geographical exposure to the virus and primarily to family rather than hospital exposure.

Details

Title
SARS-CoV-2 serology in 4000 health care and administrative staff across seven sites in Lombardy, Italy
Author
Sandri, Maria Teresa 1 ; Azzolini, Elena 1 ; Torri Valter 2 ; Carloni, Sara 3 ; Pozzi Chiara 1 ; Salvatici Michela 1 ; Tedeschi, Michele 1 ; Castoldi Massimo 4 ; Mantovani, Alberto 5 ; Rescigno, Maria 6 

 IRCCS Humanitas Research Hospital, Milan, Italy (GRID:grid.417728.f) (ISNI:0000 0004 1756 8807) 
 Mario Negri” - IRCCS, Istituto Di Ricerche Farmacologiche, Milan, Italy (GRID:grid.4527.4) (ISNI:0000000106678902) 
 Humanitas University, Department of Biomedical Sciences, Milan, Italy (GRID:grid.452490.e) 
 Humanitas Gavazzeni and Castelli, Bergamo, Italy (GRID:grid.477189.4) (ISNI:0000 0004 1759 6891) 
 IRCCS Humanitas Research Hospital, Milan, Italy (GRID:grid.417728.f) (ISNI:0000 0004 1756 8807); Humanitas University, Department of Biomedical Sciences, Milan, Italy (GRID:grid.452490.e); The William Harvey Research Institute, Queen Mary University of London, London, UK (GRID:grid.4868.2) (ISNI:0000 0001 2171 1133) 
 IRCCS Humanitas Research Hospital, Milan, Italy (GRID:grid.417728.f) (ISNI:0000 0004 1756 8807); Humanitas University, Department of Biomedical Sciences, Milan, Italy (GRID:grid.452490.e) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2539747412
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.